Brandaris Therapeutics B.V.
Develops new therapies for brain disorders.
Brandaris Therapeutics B.V. develops new medicines for neuropsychiatric disorders. The company focuses on cellular processes involved in these conditions. By influencing these processes, Brandaris aims to enable new treatment options for patients with limited alternatives. With support from investors, the company is advancing the development of its medicines.
- Datum:
- 21-06-2024
- Locatie:
- Leiden
- Sector:
- Life Sciences & Health
- Fonds:
- InnovationQuarter Capital
- Status:
- Active
- Website:
- https://brandaristx.com/
Knowledge to continue growing
Quickscan
Find out which fund fits your growth
In just 5 minutes